Thursday 7 February 2013

Europe faces cost cuts as GSK promises return to growth

LONDON (Reuters) - GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth this year, after failing to deliver a hoped-for sales and margin recovery in 2012. Britain's biggest drug...

Source: http://health.yahoo.net/news/s/nm/europe-faces-cost-cuts-as-gsk-promises-return-to-growth

explained here as explained here resource source

No comments:

Post a Comment

Note: only a member of this blog may post a comment.